We investigate a mathematical model for the dynamics between tumor cells, immuneeffector cells, and the cytokine interleukin-2 (IL-2). In order to better determine under what circumstances the tumor can be eliminated, we implement optimal control theory. We design control functionals to maximize the effector cells and interleukin-2 concentration and to minimize the tumor cells. Next, we show that an optimal control exists for each problem. After which, we characterize our optimal control in terms of the solution to the optimality system, which is the state system coupled with the adjoint system. Finally, we analyze the various optimal controls and optimality systems using numerical techniques
International audienceIn this paper, we investigate a mathematical model describing interactions bet...
We present a delay differential model with optimal control that describes the interactions of the tu...
In this paper, we consider a tumor growth mathematical model that includes an immune system and drug...
We investigate a mathematical population model of tumor-immune interactions. The populations involve...
Interactive dynamics between effector-tumor-normal cells in a mathematical model related to the grow...
AbstractA system of ordinary differential equation, which describes the interaction of HIV and T cel...
A system of ordinary differential equation, which describes the interaction of HIV and T cells in th...
This study addresses a cancer eradication model involving effector cells in the presence of gene the...
We investigate a mathematical model of tumor–immune interactions with chemotherapy, and strategies f...
In this paper, a therapeutic strategy for the treatment of cancer using immunotherapy that aims to m...
Abstract. Optimal control techniques are usedto develop optimal strategies for chemotherapy. In part...
A simple mathematical model for the growth of tumour with discrete time delay in the immune system i...
International audienceIn this paper, we investigate strategies for administering chemo-and immunothe...
We present a competition model of cancer tumor growth that includes both the immune system response ...
We present a competition model of cancer tumor growth that includes both the immune system response ...
International audienceIn this paper, we investigate a mathematical model describing interactions bet...
We present a delay differential model with optimal control that describes the interactions of the tu...
In this paper, we consider a tumor growth mathematical model that includes an immune system and drug...
We investigate a mathematical population model of tumor-immune interactions. The populations involve...
Interactive dynamics between effector-tumor-normal cells in a mathematical model related to the grow...
AbstractA system of ordinary differential equation, which describes the interaction of HIV and T cel...
A system of ordinary differential equation, which describes the interaction of HIV and T cells in th...
This study addresses a cancer eradication model involving effector cells in the presence of gene the...
We investigate a mathematical model of tumor–immune interactions with chemotherapy, and strategies f...
In this paper, a therapeutic strategy for the treatment of cancer using immunotherapy that aims to m...
Abstract. Optimal control techniques are usedto develop optimal strategies for chemotherapy. In part...
A simple mathematical model for the growth of tumour with discrete time delay in the immune system i...
International audienceIn this paper, we investigate strategies for administering chemo-and immunothe...
We present a competition model of cancer tumor growth that includes both the immune system response ...
We present a competition model of cancer tumor growth that includes both the immune system response ...
International audienceIn this paper, we investigate a mathematical model describing interactions bet...
We present a delay differential model with optimal control that describes the interactions of the tu...
In this paper, we consider a tumor growth mathematical model that includes an immune system and drug...